• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病认知衰退纵向建模中个体特异性效应的影响。

Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer's Disease.

机构信息

Department of Biostatistics, Ryals School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

Alzheimer's Disease Research Center, Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

J Alzheimers Dis. 2022;87(1):489-501. doi: 10.3233/JAD-215553.

DOI:10.3233/JAD-215553
PMID:35342087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9198753/
Abstract

BACKGROUND

Accurate longitudinal modelling of cognitive decline is a major goal of Alzheimer's disease and related dementia (ADRD) research. However, the impact of subject-specific effects is not well characterized and may have implications for data generation and prediction.

OBJECTIVE

This study seeks to address the impact of subject-specific effects, which are a less well-characterized aspect of ADRD cognitive decline, as measured by the Alzheimer's Disease Assessment Scale's Cognitive Subscale (ADAS-Cog).

METHODS

Prediction errors and biases for the ADAS-Cog subscale were evaluated when using only population-level effects, robust imputation of subject-specific effects using model covariances, and directly known individual-level effects fit during modelling as a natural control. Evaluated models included pre-specified parameterizations for clinical trial simulation, analogous mixed-effects regression models parameterized directly, and random forest ensemble models. Assessment used a meta-database of Alzheimer's disease studies with validation in simulated synthetic cohorts.

RESULTS

All models observed increases in variance under imputation leading to increased prediction error. Bias decreased with imputation except under the pre-specified parameterization, which increased in the meta-database, but was attenuated under simulation. Known fitted subject effects gave the best prediction results.

CONCLUSION

Subject-specific effects were found to have a profound impact on predicting ADAS-Cog. Reductions in bias suggest imputing random effects assists in calculating results on average, as when simulating clinical trials. However, reduction in error emphasizes population-level effects when attempting to predict outcomes for individuals. Forecasting future observations greatly benefits from using known subject-specific effects.

摘要

背景

准确的认知衰退纵向建模是阿尔茨海默病和相关痴呆症(ADRD)研究的主要目标。然而,个体效应的影响尚未得到很好的描述,这可能会对数据生成和预测产生影响。

目的

本研究旨在探讨个体效应的影响,这是 ADRD 认知衰退中一个特征不太明显的方面,使用阿尔茨海默病评估量表认知子量表(ADAS-Cog)进行测量。

方法

当仅使用群体水平效应、使用模型协方差稳健推断个体水平效应以及在建模过程中直接拟合已知的个体水平效应作为自然对照时,评估了 ADAS-Cog 子量表的预测误差和偏差。评估的模型包括临床试验模拟的预指定参数化、直接参数化的类似混合效应回归模型以及随机森林集成模型。评估使用了一个阿尔茨海默病研究的元数据库,并在模拟合成队列中进行了验证。

结果

所有模型在推断时都观察到方差增加,导致预测误差增加。除了预指定参数化之外,偏差随着推断而减小,在元数据库中增加,但在模拟中减弱。已知拟合的个体效应给出了最佳的预测结果。

结论

发现个体效应对预测 ADAS-Cog 具有深远影响。偏差的减少表明推断随机效应有助于平均计算结果,例如在模拟临床试验时。然而,误差的减少强调了在尝试预测个体结果时群体水平效应的重要性。预测未来的观察结果从使用已知的个体特定效应中大大受益。

相似文献

1
Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer's Disease.阿尔茨海默病认知衰退纵向建模中个体特异性效应的影响。
J Alzheimers Dis. 2022;87(1):489-501. doi: 10.3233/JAD-215553.
2
The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.载脂蛋白 E4 联合年龄和阿尔茨海默病评估量表 - 认知分量表可改善对临床诊断为轻度认知障碍患者的淀粉样蛋白正电子发射断层扫描状态的预测。
Eur J Neurol. 2019 May;26(5):733-e53. doi: 10.1111/ene.13881. Epub 2019 Jan 20.
3
Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.阿尔茨海默病评估量表认知分量表(ADAS-Cog)在葡萄牙轻度认知障碍和阿尔茨海默病患者中的验证研究。
Clin Neuropsychol. 2018 Jan-Dec;32(sup1):46-59. doi: 10.1080/13854046.2018.1454511. Epub 2018 Mar 23.
4
Validation of Slovenian version of ADAS-Cog for patients with mild cognitive impairment and Alzheimer's disease.验证 ADAS-Cog 斯洛文尼亚语版在轻度认知障碍和阿尔茨海默病患者中的应用。
Acta Neurol Belg. 2022 Jun;122(3):695-702. doi: 10.1007/s13760-021-01780-5. Epub 2021 Aug 23.
5
Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.轻度认知障碍和轻度阿尔茨海默病中阿尔茨海默病评估量表-认知子量表变体:随时间的变化及强化策略的影响
Alzheimers Res Ther. 2016 Feb 12;8:8. doi: 10.1186/s13195-016-0170-5.
6
Detecting Treatment Group Differences in Alzheimer's Disease Clinical Trials: A Comparison of Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB).阿尔茨海默病临床试验中治疗组差异的检测:阿尔茨海默病评估量表-认知分量表(ADAS-Cog)与临床痴呆评定量表-总盒分(CDR-SB)的比较。
J Prev Alzheimers Dis. 2018;5(1):15-20. doi: 10.14283/jpad.2018.2.
7
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.加兰他敏治疗阿尔茨海默病所致痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
8
An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.阿尔茨海默病评估量表认知分量表(ADAS-Cog)的阿拉伯文版本:信度、效度和常模数据。
J Alzheimers Dis. 2017;60(1):11-21. doi: 10.3233/JAD-170222.
9
Bayesian estimation for the accuracy of three neuropsychological tests in detecting Alzheimer's disease and mild cognitive impairment: a retrospective analysis of the ADNI database.贝叶斯估计三种神经心理学测试诊断阿尔茨海默病和轻度认知障碍准确性:ADNI 数据库的回顾性分析。
Eur J Med Res. 2023 Oct 12;28(1):427. doi: 10.1186/s40001-023-01265-6.
10
Modelling Decline in Cognition to Decline in Function in Alzheimer's Disease.阿尔茨海默病认知下降与功能下降的建模。
Curr Alzheimer Res. 2020;17(7):635-657. doi: 10.2174/1567205017666201008105429.

本文引用的文献

1
Using Real-World Data to Rationalize Clinical Trials Eligibility Criteria Design: A Case Study of Alzheimer's Disease Trials.利用真实世界数据优化临床试验入选标准设计:以阿尔茨海默病试验为例。
AMIA Annu Symp Proc. 2021 Jan 25;2020:717-726. eCollection 2020.
2
Adding cognition to AT(N) models improves prediction of cognitive and functional decline.将认知因素纳入AT(N)模型可改善对认知和功能衰退的预测。
Alzheimers Dement (Amst). 2021 Mar 31;13(1):e12174. doi: 10.1002/dad2.12174. eCollection 2021.
3
Individual changes in anthropometric measures after age 60 years: a 15-year longitudinal population-based study.
60 岁后人体测量指标的个体变化:一项基于人群的 15 年纵向研究。
Age Ageing. 2021 Sep 11;50(5):1666-1674. doi: 10.1093/ageing/afab045.
4
Differentiating traits and states identifies the importance of chronic neuropsychiatric symptoms for cognitive prognosis in mild dementia.区分特质和状态可确定慢性神经精神症状对轻度痴呆认知预后的重要性。
Alzheimers Dement (Amst). 2021 Feb 20;13(1):e12152. doi: 10.1002/dad2.12152. eCollection 2021.
5
Cognitive trajectories of patients with focal ß-amyloid deposition.局灶性 β-淀粉样蛋白沉积患者的认知轨迹。
Alzheimers Res Ther. 2021 Feb 19;13(1):48. doi: 10.1186/s13195-021-00787-7.
6
Modelling Decline in Cognition to Decline in Function in Alzheimer's Disease.阿尔茨海默病认知下降与功能下降的建模。
Curr Alzheimer Res. 2020;17(7):635-657. doi: 10.2174/1567205017666201008105429.
7
Random forests for high-dimensional longitudinal data.随机森林在高维纵向数据中的应用。
Stat Methods Med Res. 2021 Jan;30(1):166-184. doi: 10.1177/0962280220946080. Epub 2020 Aug 9.
8
Open Data Revolution in Clinical Research: Opportunities and Challenges.临床研究中的开放数据革命:机遇与挑战。
Clin Transl Sci. 2020 Jul;13(4):665-674. doi: 10.1111/cts.12756. Epub 2020 Mar 10.
9
Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease.机器学习预测模型可提高阿尔茨海默病临床试验的疗效。
J Alzheimers Dis. 2020;74(1):55-63. doi: 10.3233/JAD-190822.
10
Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease.路易体痴呆认知衰退的变异性大于阿尔茨海默病。
J Alzheimers Dis. 2020;73(4):1321-1330. doi: 10.3233/JAD-190731.